Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Showing 20 of 0 results

Not applicableEnded earlyNCT01494896
What this trial is testing

Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching

Who this might be right for
Pulmonary Arterial HypertensionChronic Obstructive Pulmonary Disease
University of Florida 9
Large-scale testing (Phase 3)Study completedNCT01841762
What this trial is testing

Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 284
Early research (Phase 1)Not Yet RecruitingNCT07368088
What this trial is testing

PNEUMOSTEM® for Improving Respiratory Outcomes in Very Premature Infants Diagnosed With Early Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Premature Infants
Samsung Medical Center 12
Not applicableStudy completedNCT01371669
What this trial is testing

Screening for Sleep Hypoxemia in Pulmonary Arterial Hypertension

Who this might be right for
Sleep Disorders
Assistance Publique - Hôpitaux de Paris 50
Not applicableUnknownNCT01383083
What this trial is testing

Effects of Iloprost Treatment in Adult Patients With Pulmonary Arterial Hypertension Related to Congenital Heart Disease

Who this might be right for
Pulmonary Arterial Hypertension
Maryknoll Medical Center 42
Early research (Phase 1)Study completedNCT03057028
What this trial is testing

Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Virginia Commonwealth University 7
Large-scale testing (Phase 3)Ended earlyNCT01739400
What this trial is testing

Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 217
Post-approval studies (Phase 4)Not Yet RecruitingNCT07759804
What this trial is testing

Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension Transitioning From Oral Selexipag

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Liquidia Technologies, Inc. 20
Large-scale testing (Phase 3)Study completedNCT00423748
What this trial is testing

Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.

Who this might be right for
Pulmonary Arterial Hypertension
Gilead Sciences 186
Not applicableStudy completedNCT03612115
What this trial is testing

Neuromuscular Electrical Stimulation in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Dokuz Eylul University 31
Testing effectiveness (Phase 2)Study completedNCT00942708
What this trial is testing

Safety and Efficacy of Fluoxetine in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of Texas Southwestern Medical Center 6
Early research (Phase 1)Study completedNCT07173738
What this trial is testing

Pharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and Furosemide

Who this might be right for
Pulmonary Arterial Hypertension
Bial - Portela C S.A. 44
Not applicableStudy completedNCT02552485
What this trial is testing

Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt Lesions

Who this might be right for
Atrial Septal DefectsVentricular Septal Defects
Universitaire Ziekenhuizen KU Leuven 93
Testing effectiveness (Phase 2)Study completedNCT04316143
What this trial is testing

Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH (Zamicastat)

Who this might be right for
Pulmonary Arterial Hypertension
Bial - Portela C S.A. 33
Not applicableUnknownNCT03810443
What this trial is testing

Prevalence of the Hyperventilation Syndrome in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Assistance Publique - Hôpitaux de Paris 50
Early research (Phase 1)Study completedNCT01165476
What this trial is testing

Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 64
Not applicableStudy completedNCT02885155
What this trial is testing

Contribution of Echocardiography to Prognostic Evaluation of Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Central Hospital, Nancy, France 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05649748
What this trial is testing

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Insmed Incorporated 91
Not applicableStudy completedNCT03889509
What this trial is testing

A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis

Who this might be right for
Pulmonary Arterial HypertensionSystemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 63
Not applicableNo Longer AvailableNCT01582438
What this trial is testing

An Open Label Access Study For Subjects Who Completed A1481156

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation